Fujisawa USA, Inc. Sees FDA Withdraw Approval of New Drug Application

Summary

The FDA has withdrawn approval of a new drug application submitted by Fujisawa USA, Inc. due to concerns over the reliability of the data supporting the application, resulting in the discontinuation of the drug's marketing and Fujisawa's voluntary request for withdrawal of approval.